Humanigen Inc (HGENQ)

[cowtown jay]

"Myelodysplastic syndrome (MDS) is a group of cancers that affect the bone marrow and blood. In MDS, immature blood cells in the bone marrow don't develop normally and instead die or become unhealthy. This can lead to a buildup of defective cells over time, which can cause problems like anemia, leukopenia, and thrombocytopenia."

https://www.mayoclinic.org/diseases-conditions/myelodysplastic-syndrome/symptoms-causes/syc-20366977#:~:text=In%20a%20healthy%20person%2C%20bone,%2Dclotting%20platelets%20(thrombocytopenia).

I will not be surprised if lenzilumab is being used in the treatment of MDS in Mayo Clinic's Investigator Initiated Trial (IIT). And I think our CMO, Dr. Michael W Schuster, could be aiding Mayo in their IIT. This is his area of expertise.

https://doctors.stonybrookmedicine.edu/provider/Michael+W+Schuster/2250408